| Nanotechnology, a tool for diagnostics and treatment of cancer A Nasir, A Khan, J Li, M Naeem, AAK Khalil, K Khan, M Qasim Current topics in medicinal chemistry 21 (15), 1360-1376, 2021 | 63 | 2021 |
| Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells A Freuchet, P Roy, SS Armstrong, M Oliaeimotlagh, S Kumar, ... Nature immunology 24 (10), 1748-1761, 2023 | 29 | 2023 |
| Breaking tolerance: the autoimmune aspect of atherosclerosis A Khan, P Roy, K Ley Nature Reviews Immunology 24 (9), 670-679, 2024 | 15 | 2024 |
| Single Cell Transcriptomics Reveals Recent CD8T Cell Receptor Signaling in Patients with Coronary Artery Disease S Iqneibi, R Saigusa, A Khan, M Oliaeimotlagh, SS Armstrong Suthahar, ... Frontiers in Immunology 14, 1239148, 2023 | 7 | 2023 |
| Characterization of HLA‐A* 33: 03 epitopes via immunoprecipitation and LC‐MS/MS A Khan, JY Shin, MK So, JH Na, S Justesen, AA Ansari, BJ Ko, SM Ahn Proteomics 22 (1-2), 2100171, 2022 | 4 | 2022 |
| Immunotherapy for atherosclerosis by targeting pro-inflammatory T cells A Khan, K Ley Cell Research 34 (7), 467-468, 2024 | 3 | 2024 |
| ThresholdR: An Automated Method for Thresholding CITE-seq-based Antibody Expression Data for Immune Cells M Oliaeimotlagh, S Kumar, A Khan, S Silas Armstrong Suthahar, ... The Journal of Immunology 212 (1_Supplement), 0261_5438-0261_5438, 2024 | | 2024 |
| Bimodal single cell RNA sequencing reveals changes in CD4+ T cell transcriptomes with age A Khan, M Oliaeimotlagh, S Kumar, C Hedrick, K Ley The Journal of Immunology 212 (1_Supplement), 0600_4979-0600_4979, 2024 | | 2024 |
| Single cell transcriptomic changes of CD8T cells in male and female patients with coronary artery disease and diabetes S Iqneibi, R Saigusa, SSA Suthahar, A Khan, M Oliaeimotlagh, R Gulati, ... The Journal of Immunology 210 (Supplement_1), 176.03-176.03, 2023 | | 2023 |
| Thresholding CITE-Seq-based Antibody Expression Data to Improve Cell Type Identification in scRNA-Seq A Khan, M Oliaeimotlagh, SSA Suthahar, S Iqneibi, F Nettersheim, K Ley The Journal of Immunology 210 (Issue 1_Supplement), 210 (1_Supplement): 249.09, 2023 | | 2023 |
| Therapeutic Options in BRCA1-Linked Breast Cancer and Systemic Approaches A Khan, A Jan, MQ Fatmi Breast Cancer: From Bench to Personalized Medicine, 265-279, 2022 | | 2022 |
| KF1601, a novel orally bioavailable inhibitor of Bcr-Abl T315I, without inducing thrombotic microangiopathy HJ Kwon, SM Ahn, K Chang, WS Kim, A Khan, D Lee, S Lee, YR Han, ... Cancer Research 81 (13_Supplement), 1462-1462, 2021 | | 2021 |